Norwich Ventures

IonPath, Inc., based in Menlo Park, California, specializes in multiplexed ion beam imaging services for pathology. Founded in 2014, the company has developed advanced ion beam imaging technology that allows for detailed analysis of tissue biopsies, including fresh, frozen, and formalin-fixed paraffin-embedded (FFPE) samples. This technology goes beyond traditional light microscopy, providing a comprehensive understanding of the tissue microenvironment through highly multiplexed quantitative single-cell analysis. By enabling healthcare providers to obtain actionable insights, IonPath's services facilitate accurate cancer diagnoses and contribute to advancements in human health.

Podimetrics, Inc. is a care management company focused on preventing diabetic foot ulcers, a significant complication of diabetes. Founded in 2011 and headquartered in Somerville, Massachusetts, Podimetrics has developed the SmartMat, a wireless monitoring system that allows patients to scan their foot temperatures at home for just 20 seconds daily. This FDA-cleared device automatically transmits data to the company's clinical support team, which monitors for any concerning findings. By integrating advanced technology with effective care management, Podimetrics enhances patient engagement and enables clinicians to achieve improved health outcomes, ultimately saving limbs, lives, and healthcare costs. The company is supported by notable investors, including Norwich Ventures and Rock Health.

Podimetrics, Inc. is a care management company focused on preventing diabetic foot ulcers, a significant complication of diabetes. Founded in 2011 and headquartered in Somerville, Massachusetts, Podimetrics has developed the SmartMat, a wireless monitoring system that allows patients to scan their foot temperatures at home for just 20 seconds daily. This FDA-cleared device automatically transmits data to the company's clinical support team, which monitors for any concerning findings. By integrating advanced technology with effective care management, Podimetrics enhances patient engagement and enables clinicians to achieve improved health outcomes, ultimately saving limbs, lives, and healthcare costs. The company is supported by notable investors, including Norwich Ventures and Rock Health.

Affera, Inc. is a medical technology company based in Watertown, Massachusetts, established in 2013. The company focuses on developing innovative systems aimed at treating cardiac arrhythmia, a common condition that affects millions globally. By designing and advancing novel medical devices, Affera seeks to address the unmet needs within the field of cardiac arrhythmia treatment, thereby enhancing the capabilities of healthcare institutions in managing this significant health issue.

ReThink Medical, Inc. is a medical device and digital health company based in San Francisco, California, specializing in the development of a wrist-worn monitoring device. Founded in 2010 and now a subsidiary of Terumo Corporation, ReThink Medical focuses on predicting and preventing heart failure hospitalizations through continuous physiological monitoring and advanced machine learning algorithms. Its flagship product, CorBand™, is designed to detect and notify users of worsening heart conditions weeks in advance, even before noticeable symptoms emerge. This proactive approach emphasizes compliance, simplicity, and accuracy, aiming to improve quality of life for patients while significantly reducing healthcare costs. The device monitors key indicators such as heartbeat rate and fluid status, enabling timely intervention and management of heart-related disorders.

Pelvalon is a medical device company focused on improving the lives of women affected by fecal incontinence and pelvic floor disorders. The company develops non-surgical therapy devices that do not contain drugs or hormones, providing effective treatment options for accidental bowel leakage. By addressing the specific needs of female pelvic and bowel health, Pelvalon aims to enhance bowel control and overall well-being for its patients.

Lexington Medical, Inc., founded in 2013 and based in Watertown, Massachusetts, specializes in the development and manufacture of medical devices, particularly minimally invasive surgical stapling solutions. The company focuses on creating innovative surgical instruments that enhance hemostatic stapling across various procedures, such as cholecystectomy, bariatric surgery, colectomy, appendectomy, and hysterectomy. By prioritizing high standards in design engineering and smart manufacturing, Lexington Medical aims to improve the efficiency of surgical operations, thereby providing health care providers and their patients with reliable outcomes.

Soffio Medical is a Boston-based company that develops medical devices aimed at treating respiratory diseases. The company's innovative approach focuses on implantable devices designed to implement an airway bypass concept. This technology allows for the venting of trapped air from areas distal to high-resistance airways, which helps to reduce residual lung volume. By alleviating symptoms associated with chronic obstructive pulmonary disease, Soffio Medical's solutions aim to enhance the quality of life for patients suffering from these conditions.

Arterys Inc. is a technology company that specializes in developing a cloud-based analytics platform designed to enhance medical imaging diagnostics. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a range of artificial intelligence solutions, including Cardio AI for cardiac image analysis, Lung AI for lung imaging, and Liver AI for liver assessments. Their platform provides radiologists with tools to visualize and quantify blood flow in the human body, facilitating improved patient care through advanced imaging techniques. The Arterys PHI Service allows physicians to access patient data remotely, enhancing the efficiency of medical practice. As a pioneer in internet-based medical imaging, Arterys combines web accessibility with FDA-cleared AI technology to deliver innovative clinical solutions aimed at transforming healthcare.

Arterys Inc. is a technology company that specializes in developing a cloud-based analytics platform designed to enhance medical imaging diagnostics. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a range of artificial intelligence solutions, including Cardio AI for cardiac image analysis, Lung AI for lung imaging, and Liver AI for liver assessments. Their platform provides radiologists with tools to visualize and quantify blood flow in the human body, facilitating improved patient care through advanced imaging techniques. The Arterys PHI Service allows physicians to access patient data remotely, enhancing the efficiency of medical practice. As a pioneer in internet-based medical imaging, Arterys combines web accessibility with FDA-cleared AI technology to deliver innovative clinical solutions aimed at transforming healthcare.

Daktari Diagnostics, Inc. is a healthcare solutions company based in Cambridge, Massachusetts, founded in 2008. The company specializes in developing portable point-of-care diagnostic platforms aimed at improving disease management worldwide, particularly in resource-poor settings. Its key offerings include the Daktari Virology platform for detecting Hepatitis C and HIV, the Daktari InSight data management service that facilitates connectivity between diagnostic systems and healthcare providers, and the Daktari Sickle Cell solution, which enables the identification of infants with sickle cell disease from a single drop of blood. Daktari's products are designed to provide real-time diagnostic information while ensuring that critical data flows efficiently throughout the healthcare system, ultimately supporting better clinical outcomes and global disease elimination efforts.

Vaxess Technologies, Inc. is a biotechnology company based in Boston, Massachusetts, founded in 2011. The company focuses on developing and commercializing innovative silk biomaterial technologies. Its key product, the MIMIX microneedle platform, facilitates the transdermal delivery of vaccines and therapeutics. This sustained release patch technology allows for a controlled release of vaccines, mimicking the natural infection process to enhance immune response and effectiveness. Vaxess's patch is engineered for stability, eliminating the need for refrigeration, which enables shipping and application in low-resource settings. In addition to its vaccine delivery systems, Vaxess is also engaged in creating novel therapies aimed at oncology care and infectious diseases, ultimately striving to improve patient outcomes with reduced treatment burdens.

Daktari Diagnostics, Inc. is a healthcare solutions company based in Cambridge, Massachusetts, founded in 2008. The company specializes in developing portable point-of-care diagnostic platforms aimed at improving disease management worldwide, particularly in resource-poor settings. Its key offerings include the Daktari Virology platform for detecting Hepatitis C and HIV, the Daktari InSight data management service that facilitates connectivity between diagnostic systems and healthcare providers, and the Daktari Sickle Cell solution, which enables the identification of infants with sickle cell disease from a single drop of blood. Daktari's products are designed to provide real-time diagnostic information while ensuring that critical data flows efficiently throughout the healthcare system, ultimately supporting better clinical outcomes and global disease elimination efforts.

Syncro Medical Innovations, Inc. develops magnetically guided enteral feeding tubes. The company’s feeding tube contains magnetic field sensor at the distal end, electrically connected to a light indicator at the proximal end of the tube. Syncro Medical Innovations, Inc. was founded in 1998 and is based in Macon, Georgia.

Svelte Medical Systems, Inc. specializes in the design, development, and commercialization of balloon-expandable stents aimed at patients undergoing percutaneous coronary intervention (PCI) for atherosclerosis treatment. The company offers the SLENDER Integrated Delivery System, a drug-eluting coronary stent-on-a-wire system that simplifies catheter use for transradial interventions, and the DIRECT Rapid Exchange System, which employs proprietary balloon designs to improve direct stenting and post-dilatation processes. Founded in 2007 by Robert, David, and Tim Fischell, Svelte is committed to addressing critical clinical challenges in the coronary stent market, focusing on enhancing stent deliverability, reducing costs, and improving device safety. The company has developed one of the lowest profile and most deliverable stents available, featuring advanced technology aimed at achieving better clinical outcomes for patients. Based in New Providence, New Jersey, Svelte operates within the $5 billion coronary stent market.

Daktari Diagnostics, Inc. is a healthcare solutions company based in Cambridge, Massachusetts, founded in 2008. The company specializes in developing portable point-of-care diagnostic platforms aimed at improving disease management worldwide, particularly in resource-poor settings. Its key offerings include the Daktari Virology platform for detecting Hepatitis C and HIV, the Daktari InSight data management service that facilitates connectivity between diagnostic systems and healthcare providers, and the Daktari Sickle Cell solution, which enables the identification of infants with sickle cell disease from a single drop of blood. Daktari's products are designed to provide real-time diagnostic information while ensuring that critical data flows efficiently throughout the healthcare system, ultimately supporting better clinical outcomes and global disease elimination efforts.

Intelligent Bio-Systems, founded in 2005 by Drs. Steven J. Gordon and Jingyue Ju, focuses on the commercialization of advanced DNA sequencing systems. The company aims to enhance the speed and reduce the cost of generating sequence data, making its technology applicable in various fields, including research, clinical applications, and DNA resequencing. Its systems are particularly valuable for cancer and HIV/AIDS applications, allowing customers to achieve low-cost throughput sequencing while ensuring high-quality data. Dr. Gordon's background includes founding Intelligent Automation Systems, which contributed significantly to the Human Genome Project, while Dr. Ju is noted for her pioneering work on fluorescent energy transfer dyes that are integral to many electrophoresis-based sequencing technologies.

Rhythmia Medical, Inc. is an early-stage medical device company specializing in the development of technologies for the treatment of cardiac arrhythmias. The company is particularly focused on creating an advanced 3D mapping system designed to enhance catheter ablation procedures for tachy-arrhythmias, including atrial fibrillation. This innovative system aims to improve visualization and navigation during these medical procedures, ultimately seeking to provide more effective treatment options for patients suffering from these conditions.

Syncro Medical Innovations, Inc. develops magnetically guided enteral feeding tubes. The company’s feeding tube contains magnetic field sensor at the distal end, electrically connected to a light indicator at the proximal end of the tube. Syncro Medical Innovations, Inc. was founded in 1998 and is based in Macon, Georgia.